Good MorningThe sell-off on Wall Street picked up momentum last week following the hotter-than-expected CPI data. The data showed an unexpected acceleration in consumer level inflation that has the FOMC on track to hike rates by another 75 basis points this week at least. The risk now is the FOMC will try to front-run the inflation because it is so far behind the curve and that would mean even more aggressive actions and possibly a 100 basis points interest rate hike. The takeaway for investors is that economic conditions are changing rapidly and soft-landing may be impossible to orchestrate.
Also on tap this week is a raft of housing data including the NAHB index, permits, starts, and existing home sales. More importantly, we'll get a read on the index of leading indicators and it is expected to be negative. If so, this would be the 5th consecutive month of negative readings and may indicate the contraction in economic activity caused by inflation and the Fed is getting worse. Featured: No Shortage Of Money In This Market (Darwin) 
|
Stocks | | | There is a very great chance the S&P 500 (NYSEARCA: SPY) could fall another 25% or more but the news is not bad for all stocks. The hurricane predicted by Jamie Dimon is upon us, some others say the economy is broken, and yet there are sectors, industries, and individual stocks that are still se... Read the Full Story |
|
From Our PartnersMarkets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE.
He lives financially free trading this One Stock Once per month... | | | | Ticker Revealed. |
|
Politics | | | The buck isn’t stopping.
The value of the U.S. dollar has been on a tear for more than a year against everything from the British pound across the Atlantic to the South Korean won across the Pacific.
After rising again Friday, the dollar is near its highest level in m... Read the Full Story |
|
Markets | | | Grocery chain operator The Kroger Company (NYSE: KR) stock is trading up 4.5% in 2022 far outperforming tech stocks and the benchmark indices. The Company operates approximately 2,800 grocery store and pharmacies under two dozen banners in the 35 states and also sells fuel through over 1,600 centers... Read the Full Story |
|
|
Markets | | |
Rates will continue to climb with inflation concerns
Finding opportunities is becoming more difficult
Could bank stocks be about to turn around and head north?
With the Fed continuing to take us into a rising interest rate cycle, you’d be forgiven for thinking that banks would b... Read the Full Story |
|
Politics | | | Shares opened lower in Europe after a day of declines for most Asian markets, as investors braced for another interest rate hike this week by the U.S. Federal Reserve.
Britain was observing a day of mourning for Queen Elizabeth II. Japan’s markets were closed for a holiday.
... Read the Full Story |
|
From Our PartnersAmerica's #1 trading champion, Chuck Hughes, wants to share his tips and tricks with you, but hurry! Time is running out. Get a free copy of "Options Trading Made Easy" when you register for the Trade of the Day eletter. Full of advice, tips, and tricks! | | Click here for the free ebook. |
|
Politics | | | Asian shares fell Monday after another week of sizable losses on Wall Street, as investors braced for another interest rate hike by the U.S. Federal Reserve.
Japan’s markets were closed for a holiday. Oil prices rose while U.S. futures declined.
On Friday, a stark warn... Read the Full Story |
|
Markets | | | Riddle me this, how do you shock investors into a two-day selling frenzy vaporizing (-20%) off your share price and (-30%) off your market cap just after releasing great earnings? Answer, by announcing a cash and stock acquisition paying 50X sales ($20 billion) for a company with $400 million ARR in... Read the Full Story |
|
Politics | | | A dozen environmental groups are starting legal challenges against the European Union's executive branch in a bid to stop the inclusion of natural gas and nuclear power generation in the bloc’s list of sustainable activities.
European Union lawmakers in July voted to add natural gas a... Read the Full Story |
|
Politics | | | The European Union’s executive branch recommended Sunday that the bloc suspend around 7.5 billion euros (dollars) in funding to Hungary over concerns about democratic backsliding and the possible mismanagement of EU money.
The European Commission, which proposes the bloc's laws and en... Read the Full Story |
|
Markets | | | The Inflation Reduction Act (IRA) was signed into law by President Joe Biden on August 16, 2022. The intent of which is to lower inflation by lowering the costs for health, raise funding for the IRS, and funding decarbonization efforts through energy and climate projects reducing carbon emissions by... Read the Full Story |
|
Monday's Early Bird Stock Of The Day Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers products for itching, hydration, aging, cracking, overnight, and specialty skincare needs like eczema. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301, a treatment for alpha-synucleinopathies; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Adagene Inc., for the discovery and development of antibody-based therapies. It also has collaborations with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France. | | View Today's Stock Pick |
|
